Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) is expected to be releasing its Q4 2025 results before the market opens on Friday, February 13th. Analysts expect Cameco to post earnings of $0.28 per share and revenue of $782.1330 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 13, 2026 at 8:00 AM ET.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last issued its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.17). The business had revenue of $313.74 million during the quarter, compared to the consensus estimate of $531.72 million. Cameco had a net margin of 15.24% and a return on equity of 8.58%. The firm’s quarterly revenue was down 14.7% compared to the same quarter last year. During the same quarter last year, the business earned ($0.01) EPS. On average, analysts expect Cameco to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Cameco Stock Down 5.0%
Shares of CCJ opened at $109.12 on Friday. The stock’s 50-day moving average price is $103.20 and its two-hundred day moving average price is $90.27. Cameco has a 12 month low of $35.00 and a 12 month high of $135.24. The company has a market capitalization of $47.52 billion, a PE ratio of 126.88 and a beta of 0.99. The company has a current ratio of 2.99, a quick ratio of 1.85 and a debt-to-equity ratio of 0.15.
Wall Street Analyst Weigh In
Read Our Latest Report on Cameco
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bison Wealth LLC boosted its stake in shares of Cameco by 16.1% during the fourth quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company’s stock valued at $1,102,000 after purchasing an additional 2,975 shares in the last quarter. United Capital Financial Advisors LLC raised its stake in Cameco by 5.3% in the 3rd quarter. United Capital Financial Advisors LLC now owns 4,527 shares of the basic materials company’s stock worth $380,000 after acquiring an additional 227 shares during the last quarter. Ausdal Financial Partners Inc. purchased a new stake in Cameco in the third quarter valued at approximately $380,000. Vise Technologies Inc. increased its stake in shares of Cameco by 20.7% in the third quarter. Vise Technologies Inc. now owns 3,861 shares of the basic materials company’s stock worth $324,000 after acquiring an additional 662 shares during the period. Finally, Certuity LLC acquired a new position in shares of Cameco in the 3rd quarter valued at about $318,000. Institutional investors own 70.21% of the company’s stock.
Cameco Company Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Further Reading
- Five stocks we like better than Cameco
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Wall Street’s New Sports Prediction Trade
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
